ReaScan CXCL13 provides a new diagnostic tool for the rapid determination of CXCL13 and helps clinicians in the treatment decision for suspected Lyme neuroborreliosis (LNB) patients. The test result is read from the test cassette with the ReaScan+ reader. The test is intended for in vitro diagnostic laboratory use by healthcare professionals.
ReaScan+ reader is sold separately (105100, Oy Reagena Ltd)
For more information & orders please contact:
firstname.lastname@example.org, +358 10 5045 200